Stock Report

Kilitch Drugs India Ltd posts consolidated PAT of Rs. 2.42 crore in Q2FY23

Posted On : 2022-11-15 22:53:40( TIMEZONE : IST )

Kilitch Drugs (India) Limited has reported Consolidated financial results for the period ended September 30, 2022.

Financial Results (Q2 FY2023) - QoQ Comparison

The company has reported total income of Rs. 30.9366 crores during the period ended September 30, 2022 as compared to Rs. 34.4241 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs. 2.4278 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 2.0862 crores for the period ended June 30, 2022.

The company has reported EPS of Rs. 1.56 for the period ended September 30, 2022 as compared to Rs. 1.34 for the period ended June 30, 2022.

Financials	Q2 FY2023	Q1 FY2023	% Change
Total Income	₹ 30.9366 crs	₹34.4241 crs	-10.13%
Net Profit	₹2.4278 crs	₹2.0862 crs	16.37%
EPS	₹1.56	₹1.34	16.42%

Financial Results (Q2 FY2023) - YoY Comparison

The company has reported total income of Rs. 30.9366 crores during the period ended September 30, 2022 as compared to Rs.23.7386 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.2.4278 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.2.1565 crores for the period ended September 30, 2021.

The company has reported EPS of Rs.1.56 for the period ended September 30, 2022 as compared to Rs.1.39 for the period ended September 30, 2021.

Financials	Q2 FY2023	Q2 FY2022	% Change
Total Income	₹ 30.9366 crs	₹23.7386 crs	30.32%
Net Profit	₹2.4278 crs	₹2.1565 crs	12.58%
EPS	₹1.56	₹1.39	12.23%

Financial Results (Half Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.65.3607 crores during the 6 Months period ended September 30, 2022 as compared to Rs.44.4173 crores during the 6 Months period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.4.5140 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.3.3442 crores for the 6 Months period ended September 30, 2021.

The company has reported EPS of Rs.2.90 for the 6 Months period ended September 30, 2022 as compared to Rs.2.15 for the 6 Months period ended September 30, 2021.

Financials	Half Year Ended FY2023	Half Year Ended FY2022	% Change
Total Income	₹65.3607 crs	₹44.4173 crs	47.15%
Net Profit	₹4.5140 crs	₹3.3442 crs	34.98%
EPS	₹2.90	₹2.15	34.88%

Shares of Kilitch Drugs (India) Limited was last trading in BSE at Rs. 172.70 as compared to the previous close of Rs. 170.95. The total number of shares traded during the day was 3844 in over 132 trades.

The stock hit an intraday high of Rs. 175.00 and intraday low of 169.85. The net turnover during the day was Rs. 665699.00.